Drug intelligence / Profile preview

68Ga-DX600

Development stage
Unknown
Lead developer
University of Melbourne
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptides
Administration
Intravenous
01

Overview

68Ga-DX600 is a radiopharmaceutical PET tracer designed for the non-invasive imaging of Angiotensin-Converting Enzyme 2 (ACE2) expression. It consists of the peptide DX600, a highly potent and selective ACE2 antagonist, conjugated to a chelator (typically DOTA) and labeled with the positron-emitting isotope Gallium-68. ACE2 is a key enzyme in the renin-angiotensin system that converts angiotensin II to angiotensin (1-7), and it is also the primary entry receptor for the SARS-CoV-2 virus. By binding specifically to the active site of ACE2, 68Ga-DX600 allows for the quantification of ACE2 density in various tissues, including the lungs, heart, and kidneys. This tracer is primarily used in research settings to study cardiovascular diseases, pulmonary fibrosis, and the pathophysiology of COVID-19.

Other names
Gallium-68 DX600Gallium68 DX600Gallium 68 DX600[68Ga]DX-60068Ga-labeled DX600
02

Targets

ACE2 (Angiotensin-converting enzyme 2)

Beyond the preview

Go deeper on 68Ga-DX600.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 68Ga-DX600.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call